Metaanalyse
Efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a meta-analysis [Retraction]
International Journal of Clinical and Experimental Medicine · 2024
DOI: 10.62347/btko8113 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Clinical and Experimental Medicine, 2024. Verfasst von Xiaoyan Meng.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Meng, X. (2024). Efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a meta-analysis [Retraction]. International Journal of Clinical and Experimental Medicine. https://doi.org/10.62347/btko8113
Vancouver
Meng X. Efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a meta-analysis [Retraction]. International Journal of Clinical and Experimental Medicine. 2024. doi:10.62347/btko8113
BibTeX
@article{Meng2024,
author = {Meng, Xiaoyan},
title = {Efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a meta-analysis [Retraction]},
journal = {International Journal of Clinical and Experimental Medicine},
year = {2024},
doi = {10.62347/btko8113}
}
EUVIMED